Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | JAK2 |
Variant | V881fs |
Impact List | frameshift |
Protein Effect | unknown |
Gene Variant Descriptions | JAK2 V881fs results in a change in the amino acid sequence of the Jak2 protein beginning at aa 881 of 1132, likely resulting in premature truncation of the functional protein (UniProt.org). V881fs has not been characterized in the scientific literature and therefore, its effect on Jak2 protein function is unknown (PubMed, Apr 2024). |
Associated Drug Resistance | |
Category Variants Paths |
JAK2 mutant JAK2 V881fs |
Transcript | NM_004972.4 |
gDNA | chr9:g.(5089742_5089743) |
cDNA | c.(2641_2640) |
Protein | p.V881fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001322195 | chr9:g.(5089742_5089743) | c.(2641_2640) | p.V881fs | RefSeq | GRCh38/hg38 |
NM_001322194.1 | chr9:g.(5089742_5089743) | c.(2641_2640) | p.V881fs | RefSeq | GRCh38/hg38 |
NM_001322195.1 | chr9:g.(5089742_5089743) | c.(2641_2640) | p.V881fs | RefSeq | GRCh38/hg38 |
NM_001322194 | chr9:g.(5089742_5089743) | c.(2641_2640) | p.V881fs | RefSeq | GRCh38/hg38 |
NM_004972.3 | chr9:g.(5089742_5089743) | c.(2641_2640) | p.V881fs | RefSeq | GRCh38/hg38 |
NM_001322194.2 | chr9:g.(5089742_5089743) | c.(2641_2640) | p.V881fs | RefSeq | GRCh38/hg38 |
NM_001322196.2 | chr9:g.(5089742_5089743) | c.(2641_2640) | p.V881fs | RefSeq | GRCh38/hg38 |
NM_001322196 | chr9:g.(5089742_5089743) | c.(2641_2640) | p.V881fs | RefSeq | GRCh38/hg38 |
NM_004972 | chr9:g.(5089742_5089743) | c.(2641_2640) | p.V881fs | RefSeq | GRCh38/hg38 |
NM_001322196.1 | chr9:g.(5089742_5089743) | c.(2641_2640) | p.V881fs | RefSeq | GRCh38/hg38 |
NM_001322195.2 | chr9:g.(5089742_5089743) | c.(2641_2640) | p.V881fs | RefSeq | GRCh38/hg38 |
NM_004972.4 | chr9:g.(5089742_5089743) | c.(2641_2640) | p.V881fs | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
JAK2 mutant | essential thrombocythemia | not applicable | N/A | Guideline | Diagnostic | JAK2 mutations aid in the diagnosis of essential thrombocythemia (NCCN.org). | detail... |
JAK2 mutant | B-cell acute lymphoblastic leukemia | not applicable | N/A | Guideline | Prognostic | JAK2 mutations are associated with a poor prognosis in patients with B-cell acute lymphoblastic leukemia (NCCN.org). | detail... |
JAK2 mutant | childhood B-cell acute lymphoblastic leukemia | not applicable | N/A | Guideline | Prognostic | JAK2 mutations are associated with a poor prognosis in pediatric patients with B-cell acute lymphoblastic leukemia (NCCN.org). | detail... |
JAK2 mutant | myelofibrosis | not applicable | N/A | Guideline | Diagnostic | JAK2 mutations aid in the diagnosis of primary myelofibrosis (NCCN.org). | detail... |